115
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis

, , , &
Pages 2101-2110 | Published online: 13 Dec 2019

References

  • Bousquet J, Lockey R, Malling H. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102(4 Pt 1):558–562. doi:10.1016/s0091-6749(98)70271-49802362
  • Huang Y, Wang C, Cao F, et al. Comparison of long-term efficacy of subcutaneous immunotherapy in pediatric and adult patients with allergic rhinitis. Allergy Asthma Immunol Res. 2019;11(1):68–78. doi:10.4168/aair.2019.11.1.6830479078
  • Asaria M, Dhami S, Van RR, et al. Health economic analysis of allergen immunotherapy (AIT) for the Management of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview. Allergy. 2018;73(2):269–283. doi:10.1111/all.1325428718981
  • Okamoto Y, Ohta N, Okano M, et al. Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan. Auris Nasus Larynx. 2014;41(1):1–5. doi:10.1016/j.anl.2013.06.00324183858
  • Incorvaia C, Mauro M, Ridolo E, et al. Patient’s compliance with allergen immunotherapy. Patient Prefer Adherence. 2008;2(3):247–251. doi:10.2147/PPA19920970
  • Manzotti G, Riario-Sforza GG, Dimatteo M, Scolari C, Makri E, Incorvaia C. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment. Eur Ann Allergy Clin Immunol. 2016;48(6):224–227.27852426
  • Kiel MA, Röder E, Gerth van Wijk R, AI MJ, Hop WC, Rutten-van MMP. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132(2):353–360. doi:10.1016/j.jaci.2013.03.01323651609
  • Lemberg ML, Berk T, Shahhosseini K, Kasche EM, Mösges R. Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Prefer Adherence. 2017;11:63–70. doi:10.2147/PPA.S12294828115832
  • Allen-Ramey F, Mao J, Blauer-Peterson C, Rock M, Nathan R, Halpern R. Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study. Curr Med Res Opin. 2017;33(11):1–24. doi:10.1080/03007995.20
  • Lipworth B, Newton J, Ram B, Small I, Schwarze J. An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel. NPJ Primary Care Respir Med. 2017;27(1):3. doi:10.1038/s41533-016-0001-y28115736
  • Canonica GW, Triggiani M, Senna GE. 360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients. Clin Mol Allergy. 2015;13(1):25. doi:10.1186/s12948-015-0029-526528081
  • Bousquet J, Reid J, van Weel C, et al. Allergic rhinitis management pocket reference 2008. Allergy. 2010;63(8):990–996. doi:10.1111/j.1398-9995.2008.01642.x
  • Musa F, Al-Ahmad M, Arifhodzic N, Al-Herz W. Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies. Hum Vaccin Immunother. 2017;13(3):514–517. doi:10.1080/21645515.2016.124363227820664
  • Ridolo E, Incorvaia C, Senna GE, Montagni M, Olivieri E, Canonica GW. Allergen immunotherapy: clinical and practical education of Italian trainees in allergy and clinical immunology schools. Eur Ann Allergy Clin Immunol. 2013;45(Suppl 2):49–52.24129088
  • Gyuyoung H, Taebum K, Han MY, Dongho N, Jungwon P. A survey of the prescription patterns of allergen immunotherapy in Korea. Allergy Asthma Immunol Res. 2013;5(5):277–282. doi:10.4168/aair.2013.5.5.27724003383
  • Marple B, Fornadley J, Patel A, et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg. 2007;136(6):S107–S124. doi:10.1016/j.otohns.2007.0217512862
  • Rhinology editorial board of Chin J Otorhinolaryngol Head Neck Surg. Guidelines for diagnosis and treatment of allergic rhinitis (2015, tianjin). Chin J Otorhinolaryngol Head Neck Surg. 2016;51:6–24. doi:10.16066/j.1672-7002.2015.08.001
  • Chinese Allergic Rhinitis Research Collaboration Group. Clinical practice specification for subcutaneous immunotherapy of allergic rhinitis. Chin Arch Otolaryngol Head Neck Surg. 2018;28(1):1–12. doi:10.16066/j.1672-7002.2018.01.001
  • Pfaar O, Demoly P, Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper. Allergy. 2014;69(7):854–867. doi:10.1111/all.1238324761804
  • Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367–372. doi:10.1111/j.1398-9995.2006.01276.x17362246
  • Bousquet PJ, Combescure C, Klossek JM, Daures JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009;123(6):1349–1354. doi:10.1016/j.jaci.2009.02.03319368963
  • Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire. J Allergy Clin Immunol. 1999;104(2):364–369. doi:10.1016/S0091-6749(99)70380-510452758
  • Egert-Schmidt AM, Kolbe JM, Mussler S, Thum-Oltmer S. Patients’ compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence. 2014;8:1475–1481. doi:10.2147/PPA.S7032625368517
  • Leader BA, Rotella M, Stillman L, Delgaudio JM, Patel ZM, Wise SK. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy. Int Forum Allergy Rh. 2016;6(5):460–464. doi:10.1002/alr.21699
  • Wadenbäck J, Arnold V. Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: a survey. Respir Med. 2013;107:361–367.23218454
  • Gelincik A, Demir S, Olgaç M, et al. High adherence to subcutaneous immunotherapy in a real-life study from a large tertiary medical center. Allergy Asthma Proc. 2017. doi:10.2500/aap.2017.38.4091
  • Sánchez J. Adherence to allergen immunotherapy improves when patients choose the route of administration: subcutaneous or sublingual. Allergol Immunopathol. 2015;43(5):436–441. doi:10.1016/j.aller.2014.04.011
  • Savi E, Peveri S, Senna G, Passalacqua G. Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach. Allergy. 2013;68(9):1193–1195. doi:10.1111/all.1219823915164
  • Wu XP, Qiu RQ, Yang XF, Shen K, Tian ST. Influence on compliance of subcutaneous immunotherapy in patients with allergic rhinitis by We-Media management. J Clin Otorhinol Head Neck Surg. 2018;32(8):591–594.
  • Blaiss MS. Important aspects in management of allergic rhinitis: compliance, cost, and quality of life. Allergy Asthma Proc. 2003;24(4):231–238.12974189
  • Cemal C, Arzu Y, Can Cemal C, et al. The “physician on call patient engagement trial” (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients. Int Forum Allergy Rhinol. 2015;5(6):487–497. doi:10.1002/alr.2146825856270